Author + information
- Received September 27, 2011
- Revision received November 27, 2011
- Accepted December 13, 2011
- Published online April 1, 2012.
- Gerald S. Bloomfield, MD, MPH⁎,
- Linda D. Gillam, MD†,
- Rebecca T. Hahn, MD†,
- Samir Kapadia, MD‡,
- Jonathon Leipsic, MD§,
- Stamatios Lerakis, MD∥,¶,
- Murat Tuzcu, MD‡ and
- Pamela S. Douglas, MD⁎,⁎ ()
- ↵⁎Reprint requests and correspondence:
Dr. Pamela S. Douglas, 7022 North Pavilion, Duke University Medical Center, PO Box 17969, Durham, North Carolina 27715
The advent of transcatheter aortic valve replacement (TAVR) is one of the most widely anticipated advances in the care of patients with severe aortic stenosis. This procedure is unique in many ways, one of which is the need for a multimodality imaging team-based approach throughout the continuum of the care of TAVR patients. Pre-procedural planning, intra-procedural implantation optimization, and long-term follow-up of patients undergoing TAVR require the expert use of various imaging modalities, each of which has its own strengths and limitations. Divided into 3 sections (pre-procedural, intraprocedural, and long-term follow-up), this review offers a single source for expert opinion and evidence-based guidance on how to incorporate the various modalities at each step in the care of a TAVR patient. Although much has been learned in the short span of time since TAVR was introduced, recommendations are offered for clinically relevant research that will lead to refinement of best practice strategies for incorporating multimodality imaging into TAVR patient care.
Dr. Gillam has a Core Lab Contract with Edwards Lifesciences. Dr. Leipsic has served on the Speaker's Bureau and MAB for Edwards Lifesciences and GE Healthcare. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
- Received September 27, 2011.
- Revision received November 27, 2011.
- Accepted December 13, 2011.
- American College of Cardiology Foundation